← Open Payments lookup

MARTIN TAMOU: Open Payments

NPI 1114785953 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$938 in 41 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $454 · 2025 $938

Food & beverage: $938
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.10$260
Teva Pharmaceuticals USA, Inc.8$195
ABBVIE INC.9$176
Neurocrine BioSciences, Inc.4$90
Otsuka America Pharmaceutical, Inc.3$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$49
Janssen Pharmaceuticals, Inc2$45
Lundbeck LLC2$37
E.R. Squibb & Sons, L.L.C.1$16

Products named: FANAPT, VRAYLAR, AUSTEDO XR, INGREZZA, ABILIFY ASIMTUFII, CAPLYTA, UZEDY, REXULTI.

Industry payments across AZ — which companies pay providers there.